Synaptogenix is a biopharmaceutical company. Co. is focused on developing a product platform based upon a drug candidate called bryostatin for the treatment of Alzheimer's disease (AD), which is in the clinical testing stage. Co. is also evaluating potential therapeutic applications of bryostatin for other neurodegenerative or cognitive diseases and dysfunctions, such as Fragile X syndrome, Multiple Sclerosis, and Niemann-Pick Type C disease, which have undergone pre-clinical testing. Co. has completed an additional analysis in connection with the confirmatory Phase 2 study, which examined moderately severe to severe AD patients treated with Bryostatin-1 in the absence of memantine. We show 1 historical shares outstanding datapoints in our SNPX shares outstanding history coverage, used to compute SNPX market cap on those dates.
Understanding the changing numbers of shares outstanding, the changing
share price, and the resulting changing SNPX market cap history over the course of time is important for investors
interested in comparing SNPX's market cap history versus its peers.
Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at
a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies,
and then calculating their respective market caps. Comparing the share price of SNPX versus a peer is one thing; comparing
SNPX market cap versus a peer is a completely different story.
Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares),
the market cap for a company like SNPX can fluctuate over the course of history.
With this page we aim to empower investors researching SNPX by allowing them to research the SNPX market cap history. |
Free SNPX Email Alerts:
Video: The Importance of Market Cap
